Hinge Health, Inc. Class A(HNGE US)
$119.25-1.621.34%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|
| Revenue | 292.7 | 390.4 | 587.9 | 646.3 | ||
| -Cost of Revenue | 98.6 | 89.8 | 118.6 | 123.0 | ||
| Gross Profit | 194.2 | 300.6 | 469.3 | 523.3 | ||
| -Operating Expenses | 324.7 | 332.5 | 1,015.7 | 1,050.7 | ||
| +Selling, General & Admin | 214.6 | 227.5 | 639.4 | 674.2 | ||
| +General And Administrative Expenses | 67.0 | 62.4 | 325.5 | 335.5 | ||
| +Selling And Marketing Expenses | 147.6 | 165.1 | 313.9 | 338.7 | ||
| +Research and Development | 110.1 | 100.8 | 368.1 | 377.3 | ||
| +Other Operating Expenses | - | 4.1 | 8.1 | -0.7 | ||
| Operating Income | -130.5 | -31.9 | -546.4 | -527.4 | ||
| +Non Operating Income | 22.0 | 20.7 | 19.1 | -86.2 | ||
| +Interest Income, Net | - | - | - | - | ||
| +Interest Income | - | - | - | - | ||
| -Interest Expense | - | - | - | - | ||
| +Other Non-Op Income | 22.0 | 20.7 | 19.1 | -86.2 | ||
| Pretax Income | -108.5 | -11.3 | -527.3 | -613.6 | ||
| -Income Tax Expense | 0.4 | 0.7 | 1.0 | 1.5 | ||
| Income from Cont Ops | -108.1 | -11.9 | -528.3 | -614.4 | ||
| -Net Extraordinary Losses | - | - | - | - | ||
| +Discounted operations | - | - | - | - | ||
| +XO & Accounting Changes | - | - | - | - | ||
| Income Incl. MI | -108.1 | -11.9 | -528.3 | -614.4 | ||
| -Minority Interests | - | - | - | - | ||
| Net Income, GAAP | -108.1 | -11.9 | -528.3 | -614.4 | ||
| -Prfrrd Div & Other | - | - | - | - | ||
| Net Income Avail To Common | -108.1 | -11.9 | -424.1 | -511.3 | ||
| Weighted Average Shs Out | 78,015,947 | 78,016,000 | 79,190,855 | 315,016,710 | ||
| EPS | -1.4 | -0.2 | -5.4 | -6.6 | ||
| Weighted Average Shs Out Dil | 78,015,947 | 78,016,000 | 81,695,500 | 323,801,000 | ||
| EPS Diluted | -1.4 | -0.2 | -5.2 | -6.6 | ||
| Millions USD (ex. Per Share) | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|
| Revenue | 292.7 | 390.4 | 587.9 | 646.3 | ||
| -Cost of Revenue | 98.6 | 89.8 | 118.6 | 123.0 | ||
| Gross Profit | 194.2 | 300.6 | 469.3 | 523.3 | ||
| -Operating Expenses | 324.7 | 332.5 | 1,015.7 | 1,050.7 | ||
| +Selling, General & Admin | 214.6 | 227.5 | 639.4 | 674.2 | ||
| +General And Administrative Expenses | 67.0 | 62.4 | 325.5 | 335.5 | ||
| +Selling And Marketing Expenses | 147.6 | 165.1 | 313.9 | 338.7 | ||
| +Research and Development | 110.1 | 100.8 | 368.1 | 377.3 | ||
| +Other Operating Expenses | - | 4.1 | 8.1 | -0.7 | ||
| Operating Income | -130.5 | -31.9 | -546.4 | -527.4 | ||
| +Non Operating Income | 22.0 | 20.7 | 19.1 | -86.2 | ||
| +Interest Income, Net | - | - | - | - | ||
| +Interest Income | - | - | - | - | ||
| -Interest Expense | - | - | - | - | ||
| +Other Non-Op Income | 22.0 | 20.7 | 19.1 | -86.2 | ||
| Pretax Income | -108.5 | -11.3 | -527.3 | -613.6 | ||
| -Income Tax Expense | 0.4 | 0.7 | 1.0 | 1.5 | ||
| Income from Cont Ops | -108.1 | -11.9 | -528.3 | -614.4 | ||
| -Net Extraordinary Losses | - | - | - | - | ||
| +Discounted operations | - | - | - | - | ||
| +XO & Accounting Changes | - | - | - | - | ||
| Income Incl. MI | -108.1 | -11.9 | -528.3 | -614.4 | ||
| -Minority Interests | - | - | - | - | ||
| Net Income, GAAP | -108.1 | -11.9 | -528.3 | -614.4 | ||
| -Prfrrd Div & Other | - | - | - | - | ||
| Net Income Avail To Common | -108.1 | -11.9 | -424.1 | -511.3 | ||
| Weighted Average Shs Out | 78,015,947 | 78,016,000 | 79,190,855 | 315,016,710 | ||
| EPS | -1.4 | -0.2 | -5.4 | -6.6 | ||
| Weighted Average Shs Out Dil | 78,015,947 | 78,016,000 | 81,695,500 | 323,801,000 | ||
| EPS Diluted | -1.4 | -0.2 | -5.2 | -6.6 | ||